Related Experiment Video
Updated: Aug 8, 2026
09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Aircrew and type 1 diabetes mellitus
Simon R Heller1, Anthony N Nicholson
1Department of Diabetes and Endocrine Medicine, University of Sheffield, Western Bank, Sheffield, UK.
Aviation, Space, and Environmental Medicine
|May 9, 2006
Summary
Strict criteria for Type 1 diabetes mellitus (DM) do not ensure hypoglycemia awareness or prevention. Cognitive function may also remain impaired post-episode, impacting operational aircrew with Type 1 DM.
Area of Science:
- Endocrinology
- Aerospace Medicine
- Neurology
Background:
- Type 1 diabetes mellitus (DM) management aims to prevent complications.
- Hypoglycemia poses risks, particularly for individuals in safety-critical roles.
- Maintaining cognitive function is crucial for operational performance.
Purpose of the Study:
- To evaluate the efficacy of stringent clinical criteria in preventing hypoglycemia in Type 1 DM.
- To assess the impact of hypoglycemia on cognitive function in Type 1 DM patients.
- To discuss the implications for operational aircrew with Type 1 DM.
Main Methods:
- Review of clinical criteria for Type 1 DM management.
- Analysis of hypoglycemia awareness and prevention rates.
- Assessment of cognitive function post-hypoglycemic episodes.
Main Results:
- Stringent clinical criteria do not guarantee hypoglycemia awareness or prevention in Type 1 DM.
- Cognitive impairment can persist long after hypoglycemia is corrected.
- These factors present significant risks for operational aircrew.
Conclusions:
- Current management strategies may be insufficient for Type 1 DM aircrew.
- Further research is needed to ensure flight safety.
- Individual risk assessment is critical for Type 1 DM patients in aviation.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...